Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psilocybin
Biotech
FDA holds psychedelic hearing as historic approval looms
Many speakers urged the FDA to ensure that as many patients as possible can access psychedelics, while a few highlighted safety concerns.
Darren Incorvaia
Sep 14, 2026 6:00pm
Psilocybin proves promising in neuropathic pain mouse study
Sep 3, 2026 2:00pm
Compass, Usona and Transcend score priority vouchers amid psychedelic push
Apr 24, 2026 3:51pm
Compass guides psychedelic to 2nd pivotal depression win
Feb 17, 2026 8:39am
Fierce Pharma
Cybin alters state to become Helus Pharma for Nasdaq trip
Dec 19, 2025 10:30am
Reunion's psychedelic reduces postpartum depression in ph. 2
Aug 18, 2025 7:52am